Cycurion, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
18. Earnings Per Share
- EARNINGS PER SHARE
| Table 18.1: Details of Basic and Dilutive Loss Per Share | ||
|---|---|---|
| For the Three Months Ended March 31, | ||
| 2026 | 2025 | |
| Basic net loss per share: | ||
| Numerator | ||
| Net loss including non-controlling interests | $(2,561,786) | $(10,248,486) |
| Less: Net loss attributable to non-controlling interest | (433,324) | - |
| Net loss attributable to common stockholders - basic | $(2,128,462) | $(10,248,486) |
| Denominator | ||
| Weighted average shares outstanding - basic | 4,561,976 | 658,218 |
| Basic net loss per share attributable to common stockholders | $(0.47) | $(15.57) |
| Diluted net loss per share: | ||
| Numerator | ||
| Net loss attributable to common stockholders - basic | $(2,128,462) | $(10,248,486) |
| Add back interest for subordinated convertible promissory note | - | 5,000 |
| Net loss attributable to common stockholders - diluted | $(2,128,462) | $(10,243,486) |
| Denominator | ||
| Weighted average shares outstanding - basic | 4,561,976 | 658,218 |
| Weighted-average effect of potentially dilutive securities: | ||
| Conversion of subordinated convertible promissory note | - | 3,360 |
| Conversion of Series A Convertible Preferred Stock | - | 77,860 |
| Conversion of Series B Convertible Preferred Stock | - | 38 |
| Conversion of Series C Convertible Preferred Stock | - | 1,212 |
| Exercise of investor and placement agent warrants | - | 640,243 |
| Weighted average shares outstanding - diluted | 4,561,976 | 1,383,507 |
| Dilutive net loss per share attributable to common stockholders | $(0.47) | $(7.40) |
| Table 18.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect | ||
|---|---|---|
| For the Three Months Ended March 31, | ||
| 2026 | 2025 | |
| Conversion of Series B Convertible Preferred Stock | 1,347 | - |
| Conversion of Series C Convertible Preferred Stock | 1,202 | - |
| Conversion of Series D Convertible Preferred Stock | 10,092 | - |
| Conversion of Series E Convertible Preferred Stock | 51 | - |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.